Jasper Stevens

ResearcherID Scopus Author ID Researcher ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 18

Top Venues

Diabetes, obesity & metabolism

British journal of clinical pharmacology

Journal of pharmacokinetics and pharmacodynamics

Clinical pharmacology and therapeutics

Universitair Medisch Centrum Groningen

Leiden Amsterdam Centre for Drug Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitair Medisch Centrum Groningen Sep 01 2016

Netherlands

Ass. Professor :: Clinical Pharmacy and Pharmacology

Centre for Human Drug Research - Sep 01 2016

Netherlands

Pharmacometrician :: Pharmacometrics

Indiana University School of Medicine

United States

Disease and Therapeutic Response Modeling Fellow :: Dept. Medicine, Div Clinical Pharmacology

Education History

Leiden Amsterdam Centre for Drug Research

Netherlands

PHD :: Pharmacology

Rijksuniversiteit Groningen

Netherlands

MSC :: Biology

Publications

Sjoukje van der Hoek, Jeroen V Koomen, Erik J M van Bommel, Charlotte M Mosterd, Rosalie A Scholtes, Anne C Hesp, Jasper Stevens, Daniel H van Raalte, Hiddo J Lambers Heerspink
Exposure-Response Analysis of the Sodium-Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes. Journal of personalized medicine 13 (5) (2023)
Sjoukje van der Hoek, Antoon Tm Willemsen, Ton Visser, Andre Heeres, Douwe Johannes Mulder, Reinoud Ph Bokkers, Riemer Hja Slart, Philip H Elsinga, Hiddo Jl Heerspink, Jasper Stevens
Feasibility study to assess canagliflozin distribution and sodium-glucose co-transporter 2 occupancy using [ 18 F]Canagliflozin in patients with type 2 diabetes. Clinical pharmacology and therapeutics (2023)
Sjoukje van der Hoek, Douwe Johannes Mulder, Antoon T M Willemsen, Ton Visser, Andre Heeres, Riemer H J A Slart, Philip H Elsinga, Hiddo J L Heerspink, Jasper Stevens
Studying Telmisartan Plasma Exposure, Kidney Distribution, Receptor Occupancy, and Response in Patients With Type 2 Diabetes Using [ 11 C]Telmisartan. Clinical pharmacology and therapeutics 112 (6) (2022)
Michiel Joost van Esdonk, Jasper Stevens
The power of modelling pulsatile profiles. Journal of pharmacokinetics and pharmacodynamics 48 (3) (2021)
Charlotte Bakker, Samantha Prins, Jan Liptrot, Ellen P Hart, Erica S Klaassen, Giles A Brown, Alastair Brown, Miles Congreve, Malcolm Weir, Fiona H Marshall, Jasper Stevens, David M Cross, Tim Tasker, Pradeep J Nathan, Geert Jan Groeneveld
Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1 -acetylcholine receptor agonist: A randomized cross-over trial. British journal of clinical pharmacology 87 (11) (2021)
Maaike K van Gelder, Jasper Stevens, Tobias T Pieters, Koen R D Vaessen, Jaap A Joles, Marianne Christina Verhaar, Karin G F Gerritsen
Simplified Iohexol-Based Method for Measurement of Glomerular Filtration Rate in Goats and Pigs. Biology 10 (6) (2021)
Michiel Joost van Esdonk, Jacobus Burggraaf, Marion Dehez, Piet H van der Graaf, Jasper Stevens
Quantification of the endogenous growth hormone and prolactin lowering effects of a somatostatin-dopamine chimera using population PK/PD modeling. Journal of pharmacokinetics and pharmacodynamics 47 (3) (2020)
Jasper Stevens, Mireille A Wessels, Jan Roggeveld, Remco A Koster, Claire C J Dekkers, Maaike K van Gelder, Ron T Gansevoort, Hiddo J Lambers Heerspink, Daniel J Touw
UHPLC-MS/MS method for iohexol determination in human EDTA and lithium-heparin plasma, human urine and in goat- and pig EDTA plasma. Bioanalysis 12 (14) (2020)
Sebastiaan Camiel Goulooze, Annelieke C Kruithof, Shanavas Alikunju, Anirudh Gautam, Jacobus Burggraaf, Ingrid M C Kamerling, Jasper Stevens
The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL-17822 in healthy male volunteers. British journal of clinical pharmacology 86 (10) (2020)
Michiel Joost van Esdonk, Jacobus Burggraaf, Piet H van der Graaf, Jasper Stevens
Model informed quantification of the feed-forward stimulation of growth hormone by growth hormone-releasing hormone. British journal of clinical pharmacology 86 (8) (2020)
Marjolein Y A M Kroonen, Jeroen V Koomen, Sergei I Petrykiv, Gozewijn D Laverman, Hiddo J Lambers Heerspink, Jasper Stevens
Exposure-response relationships for the sodium-glucose co-transporter-2 inhibitor dapagliflozin with regard to renal risk markers. Diabetes, obesity & metabolism 22 (6) (2020)
Jeroen V Koomen, Jasper Stevens, George L Bakris, Ricardo Correa-Rotter, Fan Fan Hou, Dalane W Kitzman, Donald Kohan, Hirofumi Makino, John Joseph Valentine McMurray, Hans-Henrik Parving, Vlado Perkovic, Sheldon W Tobe, Dick de Zeeuw, Hiddo J Lambers Heerspink
Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trial. Diabetes, obesity & metabolism 23 (2) (2020)
Jeroen V Koomen, Jasper Stevens, Hiddo J Lambers Heerspink
Exposure-response relationships of dapagliflozin on cardiorenal risk markers and adverse events: A pooled analysis of 13 phase II/III trials. British journal of clinical pharmacology 86 (11) (2020)
Jeroen V Koomen, Hiddo J Lambers Heerspink, Ilse C Schrieks, Gregory G Schwartz, A Michael Lincoff, Stephen J Nicholls, Anders Svensson, Hans Wedel, Arlette Weichert, Diederick E Grobbee, Jasper Stevens
Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial. Diabetes, obesity & metabolism 22 (1) (2019)
Marjolein Y A M Kroonen, Jasper Stevens, Dick de Zeeuw, Hiddo J Lambers Heerspink
Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin. Diabetes, obesity & metabolism 21 (12) (2019)
Natalia V Ortiz Zacarías, Anneke C Dijkmans, Jacobus Burggraaf, Johan W Mouton, Erik B Wilms, Cees van Nieuwkoop, Daan J Touw, Ingrid M C Kamerling, Jasper Stevens
Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens. Pharmacology research & perspectives 6 (1) (2018)
Jeroen V Koomen, Jasper Stevens, Nael M Mostafa, Hans-Henrik Parving, Dick de Zeeuw, Hiddo J Lambers Heerspink
Determining the optimal dose of atrasentan by evaluating the exposure-response relationships of albuminuria and bodyweight. Diabetes, obesity & metabolism 20 (8) (2018)
Michiel Joost van Esdonk, Eline J M van Zutphen, Ferdinand Roelfsema, Alberto M Pereira, Piet H van der Graaf, Nienke R Biermasz, Jasper Stevens, Jacobus Burggraaf
How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review. Pituitary 21 (3) (2018)

Jasper Stevens.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jasper Stevens